.@UAMatulonis, chief of #GynOnc at @DanaFarber, shares game-changing insights from #SGO2024 on endometrial cancer trials. Breakdown includes pivotal RUBY study, NRG GY018 trial, and exploration of PARP inhibitors. Stay tuned for more advancements. https://t.co/nWlO5QChJL
@abe_verghese @peterblackstock @groveatlantic@Center4Fiction Dear @abe_verghese, it was, for certain, strong editorial guidance ... I found myself intentionally slowing down when I reached the last 100 pages. I didn't want it to end! Thanks for such a phenomenal read, every page was worth it.
How can a country that has required you to take your shoes off at airport security for a 2001 foiled attempt without a single person hurt ......
be the same one that has no systematic plan to address >73,000 Americans dead, >1.2 million confirmed cases?
Dr. Andrew Thomas is a hand surgeon in Minneapolis. Years ago he was a med student @ColumbiaPS. Today he’s back as a volunteer in our OR ICU pods, sleeping in his old room at Bard Hall & working on the frontlines.
He wrote a letter to friends back home: https://t.co/hUr6PHYp9a